Overslaan en naar de inhoud gaan

 Alle verbonden artikelen

Characterization of TET and IDH gene expression in chronic lymphocytic leukemia: comparison with normal B cells and prognostic significance.

Auteurs : Van Damme M, Crompot E, Meuleman N, Maerevoet M, Mineur P, Bron D, Lagneaux L, Stamatopoulos B
Jaar : 2016
Journal : Clin Epigenetics
Volume : 8
Pagina's : 132

Mesenchymal stromal cells from the foreskin: Tissue isolation, cell characterization and immunobiological properties.

Auteurs : Najar M, Raicevic G, André T, Fayyad-Kazan H, Pieters K, Bron D, Toungouz M, Lagneaux L
Jaar : 2016
Journal : Cytotherapy
Volume : 18
Pagina's : 320-35

The Immunomodulatory Potential of Mesenchymal Stromal Cells: A Story of a Regulatory Network.

Auteurs : Najar M, Raicevic G, Crompot E, Fayyad-Kazan H, Bron D, Toungouz M, Lagneaux L
Jaar : 2016
Journal : J Immunother
Volume : 39
Pagina's : 45-59

The protein phosphatase 2A regulatory subunit PR70 is a gonosomal melanoma tumor suppressor gene.

Auteurs : Van Kempen LC, Redpath M, Elchebly M, Klein KO, Papadakis AI, Wilmott JS, Scolyer RA, Edqvist PH, Pontén F, Schadendorf D, van Rijk AF, Michiels S, Dumay A, Helbling-Leclerc A, Dessen P, Wouters J, Stass M, Greenwood CM, Ghanem G, van den Oord J, Feunteun J, Spatz A
Jaar : 2016
Journal : Sci Transl Med
Volume : 8
Pagina's : 369ra177

Mesenchymal stromal cells and immunomodulation: A gathering of regulatory immune cells.

Auteurs : Najar M, Raicevic G, Fayyad-Kazan H, Bron D, Toungouz M, Lagneaux L
Jaar : 2016
Journal : Cytotherapy
Volume : 18
Pagina's : 160-71

Improved Treatment of Breast Cancer with Anti-HER2 Therapy Requires Interleukin-21 Signaling in CD8+ T Cells.

Auteurs : Mittal D, Caramia F, Michiels S, Joensuu H, Kellokumpu-Lehtinen PL, Sotiriou C, Loi S, Smyth MJ
Jaar : 2016
Journal : Cancer Res
Volume : 76
Pagina's : 264-74

Serum free light chains should be the target of response evaluation in light chain multiple myeloma rather than urines.

Auteurs : Dejoie T, Corre J, Caillon H, Hulin C, Perrot A, Caillot D, Boyle E, Chretien ML, Fontan J, Belhadj K, Brechignac S, Decaux O, Voillat L, Rodon P, Fitoussi O, Araujo C, Benboubker L, Fontan C, Tiab M, Godmer P, Luycx O, Allangba O, Pignon JM, Fuzibet JG, Legros L, Stoppa AM, Dib M, Pegourie B, Orsini-Piocelle F, Karlin L, Arnulf B, Roussel M, Garderet L, Mohty M, Meuleman N, Doyen C, Lenain P, Macro M, Leleu X, Facon T, Moreau P, Attal M, Avet-Loiseau H
Jaar : 2016
Journal : Blood
Volume : 128(25)
Pagina's : 2941-48

Somatic mutation, copy number and transcriptomic profiles of primary and matched metastatic estrogen receptor-positive breast cancers.

Auteurs : Fumagalli D, Wilson TR, Salgado R, Lu X, Yu J, OBrien C, Walter K, Huw LY, Criscitiello C, Laios I, Jose V, Brown DN, Rothé F, Maetens M, Zardavas D, Savas P, Larsimont D, Piccart-Gebhart M, Michiels S, Lackner MR, Sotiriou C, Loi S
Jaar : 2016
Journal : Ann Oncol
Volume : 27
Pagina's : 1860-6

Prognostic value of CALR vs. JAK2V617F mutations on splenomegaly, leukemic transformation, thrombosis, and overall survival in patients with primary fibrosis: a meta-analysis.

Auteurs : Kourie HR, Ameye L, Paesmans M, Bron D
Jaar : 2016
Journal : Ann Hematol
Volume : 95(12)
Pagina's : 2105-2106

The Genomic Grade Assay Compared With Ki67 to Determine Risk of Distant Breast Cancer Recurrence.

Auteurs : Ignatiadis M, Azim HA Jr, Desmedt C, Veys I, Larsimont D, Salgado R, Lyng MB, Viale G, Leyland-Jones B, Giobbie-Hurder A, Kammler R, Dell orto P, Rothé F, Laïos I, Ditzel HJ, Regan MM, Piccart-Gebhart M, Michiels S, Sotiriou C
Jaar : 2016
Journal : JAMA Oncol
Volume : 2(2)
Pagina's : 217-24

Feasibility Study of EndoTAG-1, a Tumor Endothelial Targeting Agent, in Combination with Paclitaxel followed by FEC as Induction Therapy in HER2-Negative Breast Cancer.

Auteurs : Ignatiadis M, Zardavas D, Lemort M, Wilke C, Vanderbeeken MC, Dhondt V, de Azambuja E, Gombos A, Lebrun F, Dal Lago L, Bustin F, Maetens M, Ameye L, Veys I, Michiels S, Paesmans M, Larsimont D, Sotiriou C, Nogaret JM, Piccart-Gebhart M, Awada A
Jaar : 2016
Journal : PLoS One
Volume : 11(7)
Pagina's : e0154009

Vulnerabilities in Older Patients when Cancer Treatment is Initiated: Does a Cognitive Impairment Impact the Two-Year Survival?

Auteurs : Libert Y, Dubruille S, Borghgraef C, Etienne AM, Merckaert I, Paesmans M, Reynaert C, Roos M, Slachmuylder JL, Vandenbossche S, Bron D, Razavi D
Jaar : 2016
Journal : PLoS One
Volume : 11
Pagina's : e0159734

Data on nitric oxide production by human bone marrow-derived mesenchymal stromal cells.

Auteurs : Najar M, Fayyad-Kazan M, Fayyad-Kazan H, Meuleman N, Bron D, Lagneaux L
Jaar : 2016
Journal : Data Brief
Volume : 8
Pagina's : 1111-4

Risk-adapted transplant strategies for high-risk Hodgkin lymphoma: are we there?

Auteurs : Lewalle P, Wittnebel S
Jaar : 2016
Journal : Curr Opin Oncol
Volume : 28
Pagina's : 390-7

Tumor-Infiltrating Lymphocytes and Associations With Pathological Complete Response and Event-Free Survival in HER2-Positive Early-Stage Breast Cancer Treated With Lapatinib and Trastuzumab: A Secondary Analysis of the NeoALTTO Trial.

Auteurs : Salgado R, Denkert C, Campbell C, Savas P, Nucifero P, Aura C, de Azambuja E, Eidtmann H, Ellis CE, Baselga J, Piccart-Gebhart M, Michiels S, Bradbury I, Sotiriou C, Loi S
Jaar : 2015
Journal : JAMA Oncol
Volume : 1(4)
Pagina's : 448-54

Isolation and Characterization of Human Mesenchymal Stromal Cell Subpopulations: Comparison of Bone Marrow and Adipose Tissue.

Auteurs : Busser H, Najar M, Raicevic G, Pieters K, Velez Pombo R, Philippart P, Meuleman N, Bron D, Lagneaux L
Jaar : 2015
Journal : Stem Cells Dev.
Volume : 24(18)
Pagina's : 2142-57

Avoiding false positive antigen detection by flow cytometry on blood cell derived microparticles: the importance of an appropriate negative control.

Auteurs : Crompot E, Van Damme M, Duvillier H, Pieters K, Vermeesch M, Perez-Morga D, Meuleman N, Mineur P, Bron D, Lagneaux L, Stamatopoulos B
Jaar : 2015
Journal : PLoS One
Volume : 10(5)
Pagina's : e0127209

Aging and malignant hemopathies.

Auteurs : Bron D, Ades L, Fulop T, Goede V
Jaar : 2015
Journal : Haematologica
Volume : 100(5)
Pagina's : 571-4

Access to human tissues for research and product development: From EU regulation to alarming legal developments in Belgium.

Auteurs : Pirnay JP, Baudoux E, Cornu O, Delforge A, Delloye C, Guns J, Heinen E, Van den Abbeel E, Vanderkelen A, Van Geyt C, van Riet I, Verbeken G, De Sutter P, Verlinden M, Huys I, Cockbain J, Chabannon C, Dierickx K, Schotsmans P, De Vos D, Rose T, Jennes S, Sterckx S
Jaar : 2015
Journal : EMBO Rep.
Volume : 16(5)
Pagina's : 557-62

Aging and blood disorders: new perspectives, new challenges.

Auteurs : Bron D, Ades L, Fulop T, Goede V, Stauder R
Jaar : 2015
Journal : Haematologica
Volume : 100(4)
Pagina's : 415-7